Navigation Links
NeurogesX Reports Fourth Quarter and Year-End 2008 Results
Date:3/20/2009

burn rate; expectations with respect to seeking funding; the potential markets for NeurogesX' product candidates; and the expected benefits of NeurogesX' product candidates;. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to, positive results in clinical trials, or the recommendation of the CHMP for MAA approval, may not be sufficient to obtain FDA or European regulatory approval; any regulatory approvals which are received may offer more limited indications than anticipated; unexpected expenses; inability to enter into or obtain adequate funding under commercial or other strategic partnerships; NeurogesX' product candidates may have unexpected adverse side effects or inadequate therapeutic efficacy; physician or patient reluctance to use Qutenza or NGX-1998, if approved, or the inability of physicians to obtain sufficient reimbursement for such procedures; potential alternative therapies; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; and other difficulties or delays in, clinical development, obtaining regulatory approval, market acceptance and commercialization of NeurogesX' product candidates and the advantages of NeurogesX' product candidates over other pain therapies. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission.

                                   NEUROGESX, INC.
                           (A Development Stage Company)

                  CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                  (in thousands, except share and per share data)
                                     (unaudited)

                                     Three Months Ended   Twelve Months Ended
                                    
'/>"/>
SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
2. NeurogesX Reports Fourth Quarter and Year-End 2007 Financial Results
3. NeurogesX to Present at Susquehanna Financial Groups 2nd Annual SIGnificant Options in Healthcare Conference
4. NeurogesX to Present at RBC Capital Markets 2007 Healthcare Conference
5. NeurogesX to Report Third Quarter 2007 Financial Results on November 14, 2007
6. The NewsHour With Jim Lehrer Reports From South Africa on Renewed Efforts to Combat HIV/AIDS and Tuberculosis
7. Medical symposium highlights importance of case reports -- patient stories in modern medicine
8. Secova Reports Healthcare Provisions In The Stimulus Bill
9. Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports
10. Shamir Optical Industry Ltd. Reports Fourth Quarter and Year-End 2008 Results
11. China Pharma Holdings, Inc. Reports Record 2008 Year End Financial Results and Corporate Updates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... July 03, 2015 , ... First Choice Emergency Room , the ... Manzanares, MD as the new Medical Director of its Frisco facility. , “We are ... Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Every year, ... 24-Hour Train-a-Thon where they provide members of the Red Deer community with free fitness ... day of fitness training, games, food, events and entertainment raised thousands of charity dollars ...
(Date:7/2/2015)... Richmond, VA (PRWEB) , ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased ... the 18th sweetFrog store located in the Lone Star State. The premium frozen yogurt chain ... , The store, which opened June 19 in the Village at Bachman Lake, is located ...
(Date:7/2/2015)... ... July 02, 2015 , ... The American Association ... of the Stop Overdose Stat (S.O.S.) Act of 2015 on June 23, 2015. ... Act seeks to decrease drug overdose – especially of heroin and opioid medication ...
(Date:7/2/2015)... ... 02, 2015 , ... With summer in full swing, Americans are flocking to Canada’s many lakes ... spots for fishing in the world, and it’s easy to understand why. From the Pacific ... fish. , Recreational fishing is a huge industry, and Americans make up the vast ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3
... Molecular Biology Organization (EMBO) today announced Simon Boulton of ... as the winner of the 2011 EMBO Gold Medal. ... contributions of young researchers in the molecular life sciences. ... groundbreaking research on DNA repair mechanisms. The election committee ...
... (HealthDay News) -- New research finds that adults who suffered ... hay fever -- are nine times more likely to have ... findings are based on about 1,400 adults who have been ... Health Study. The study participants were assessed in 1968, when ...
... announced today the U.S. Department of Defense (DOD) Breast ... Congressionally Directed Medical Research Programs has awarded Silvia Formenti, ... of the Department of Radiation Oncology a $4.5 million ... "This Multi-Team Award offers tremendous promise for new ...
... -- About 1 in 8 children infected with HIV ... resistant to multiple drugs -- within five years of ... drug failure rate is higher than in adults and ... young patients who begin antiretroviral therapy so early in ...
... TUESDAY, April 19 (HealthDay News) -- Certain gene mutations ... if that advice runs counter to experience, say researchers ... 70 volunteers with and without gene mutations that affect ... of the brain called the prefrontal cortex and the ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, April ... years for the diagnosis of Alzheimer,s disease could double the ... The guidelines, issued Tuesday by the Alzheimer,s Association and the ... from the last recommendations, which have been in use since ...
Cached Medicine News:Health News:EMBO Gold Medal 2011 awarded to Simon Boulton 2Health News:EMBO Gold Medal 2011 awarded to Simon Boulton 3Health News:Kids' Eczema, Hay Fever Linked to Allergic Asthma Later 2Health News:NYU Langone Medical Center awarded $4.5 million for breast cancer research 2Health News:Children With HIV at Higher Risk of Drug Resistance 2Health News: Alzheimer's Cases Could Double With New Guidelines: Expert 2Health News: Alzheimer's Cases Could Double With New Guidelines: Expert 3
(Date:7/4/2015)... BARCELONA, Spain , July 4, 2015 /PRNewswire/ ... to first-line chemotherapy for patients with unresectable metastatic ... Progression-Free Survival in that organ Patients ... spread only to the liver experienced the greatest ... from the addition of SIR-Spheres Y-90 resin microspheres ...
(Date:7/3/2015)... A global continuing medical education ... thyroid disorders in Latin America ... dedicated to these diseases.      (Logo: http://photos.prnewswire.com/prnh/20150630/227033) ... Manage Hypertension Online and Manage Thyroid Online ... - combine the world,s top expertise with dynamic ...
(Date:7/2/2015)... 2015 BGI a annoncé aujourd,hui que ... l,ADN situé à Hong Kong ... of Pathologists  (Collège des pathologistes américains, ou CAP). ... Kong constituent le premier laboratoire clinique ... certification du CAP en Chine, car il satisfait ...
Breaking Medicine Technology:New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 2New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 3New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer 4Combating Three Major Chronic Diseases in Latin America With Medical Education 2BGI obtient la certification du Collège des pathologistes américains (CAP) 2
... performance and value., ,The Aestiva/5 7100 ... the Aestiva/5 anesthesia system (open architecture, integrated ... newest anesthesia ventilation platform - the 7100 ... engineered to allow for ventilation of a ...
... ventilation., ,The Aestiva/5 offers exceptional capabilities ... to anesthesia therapy., ,The Aestiva/5 with ... intensive care ventilator, saving you the cost ... the OR. Its flexible ergonomic design and ...
... An integrated approach to quality patient care., ... an innovative approach to anesthesia delivery. As ... combines enhanced ventilation features, electronically controlled gas ... and information management to create a truly ...
... FlexiGel Strands® Absorbent Wound Dressing is a sterile, ... in moist wound dressing applications. The synthetic ... to the wound contours, and entraps slough and ... debridement. The strands of the matrix are ...
Medicine Products: